HOT NEWS
AstraZeneca
AstraZenecaAstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca.com.

AstraZeneca RSS Channel

Title Filter     Display # 
# Article Title Hits
1 AstraZeneca and Karolinska Institutet to create Integrated Translational Research Centre 1971
2 Pascal Soriot appointed Chief Executive Officer of AstraZeneca 3035
3 Data results of the PLATelet inhibition and patient Outcomes (PLATO) trial's health economics substudy 5017
4 Innovative public-private collaboration launches to tackle antibiotic research 3619
5 FORXIGA (dapagliflozin) receives positive CHMP opinion 4679
6 AstraZeneca and IMS Health announce real-world evidence collaboration in Europe 5659
7 Groundbreaking scientific collaboration gives UK academia access to compounds to advance medical research 5993
8 KOMBOGLYZE™ receives marketing authorisation in the European Union 6140
9 CAPRELSA™ (vandetanib) receives positive CHMP opinion 9710
10 AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE at ISPOR EU 6693
11 BRILIQUE receives a positive preliminary medical benefit assessment 7112
12 Additional Analyses from PLATO Presented at ESC Congress 5152
13 Positive agreement received for approval of AXANUM in Europe 6483
14 AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg 6235
15 AstraZeneca and Heptares collaborate to investigate important GPCR drug targets 6419
16 Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment 6055
17 European Commission approves nasal spray vaccine FLUENZ 7367
18 AstraZeneca and Abbott end license agreement for the development of Certriad 6975
19 European Commission Approves Brilique™ (Ticagrelor Tablets) 7267
20 Positive agreement received for approval of VIMOVO in Europe 7708
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3